CTRI/2021/12/038971Not yet recruitingPhase 1
A Pre-clinical study and Pilot clinical study on Sharapunkhadi Granules in childhood sickle cell anemia - SG - SCA
Dr Pinakumari Patel0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Pre diagnosed cases will be taken only.
- •Age between 3 years to 16 years irrespective of gender caste religion
- •Patients with sign and symptoms of sickle cell anaemia
- •Hb >6.5 gm% and <11.5 gm%
- •Hb electrophoresis reporting % of Hb S >10 gm%
- •Serum Bilirubin less than 3.0 mg/dL
Exclusion Criteria
- •Age less than 3 years and greater than 16 years
- •Patients with known case of Hepatic, Renal Dysfunction Chronic Cardiac Dysfunction
- •SCA associated with other known diseases like Diabetes Mellitus Hypertension
- •Hb < 6.5 gm% and >11.5 gm%.
- •Serum bilirubin level more than 3.0mg/dL
- •Known case of other Haemoglobinopathies and Haematological diseases other than Sickle cell anaemia G6PD Thalassemia Sickle cell beta thalassemia
Investigators
Similar Trials
Not yet recruiting
Phase 2
â??Clinical trial of Siddha drugs Parangipattai Kudineer (Internally) and Sivappu Thylam (Externally) in the treatment of Kalanjaga Padai (Psoriasis) with and without Yogam therapyâ??CTRI/2018/07/015115Dr K Archana
Completed
Phase 1
An Experimental and clinical trial to study the effect of Triphala RasayanaCTRI/2020/07/026483RGGPG Ayurvedic College and Hospital Paprola28
Not yet recruiting
Phase 1
Study to evaluate the effect of Suvarnaprashan yoga on growth and development in ChildreCTRI/2023/05/052262RGGPG Ayurvedic College
Not yet recruiting
Not Applicable
To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.CTRI/2021/05/033863Principal
Recruiting
Phase 1
MK-4280 and Pembrolizumab in Hematologic MalignanciesCTIS2023-503587-17-00Merck Sharp & Dohme LLC140
